tesaglitazar regulates insulin sensitivity
Evidence from:
primary |
all sources
Evidence (2 sources)
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
improvements ... in insulin sensitivity ... seen in both humans and rodents
confidence: 0.95
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
This treatment effect was so profound that it enabled quantitative estimation of insulin sensitivity (EC50 value for R g′) in a number of tissues of the obese rat for the Tesaglitazar treated group.
confidence: 0.94